Custom pharmaceutical development and manufacturing company IriSys has established a business development office in Shanghai. The office is staffed by business development manager, Leonard Shi. IriSys says it has implemented a strategy to focus on Asia, bridging the gap between innovators there and access to the U.S. regulatory infrastructure and markets. “In addition to our capabilities in formulation and novel drug delivery techniques, our FDA consulting services will be of great value t...